Allergan, Pfizer call off proposed $160B merger

The biggest U.S.-based drugmaker, Pfizer Inc., will stay put thanks to aggressive new Treasury Department rules that succeeded in blocking Pfizer from acquiring rival Allergan and moving to Ireland - on paper - to reduce its tax bill.